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Abstract
Introduction:  Undifferentiated Liver Sarcoma, also known as Undifferentiated Embryonal
Sarcoma of the Liver, is a rare, highly malignant neoplasm which affects mostly the pediatric
population, although a few cases have been reported in adults. It accounts for about 13% of
pediatric hepatic malignancies.
Case presentation: We report a case of undifferentiated liver sarcoma in a 14-year-old Chinese
boy who presented with non-specific right hypochondriac pain. Exploratory laparotomy with
tumor resection was performed, followed by adjuvant chemotherapy.
Conclusion: Undifferentiated Liver Sarcoma is a rare, highly malignant hepatic neoplasm affecting
almost exclusively the pediatric population. The prognosis is poor but recent evidence shows that
long-term survival is possible after complete surgical resection and postoperative chemotherapy.
Introduction
Undifferentiated Liver Sarcoma (ULS), also known as
Undifferentiated Embryonal Sarcoma of the Liver, is a
rare, highly malignant neoplasm which affects mostly the
pediatric population, although a few cases have been
reported in adults. It accounts for about 13% of pediatric
hepatic malignancies. Only about 150 cases have been
reported in the literature. Undifferentiated Liver Sarcoma
was named as a separate entity by Stocker et al on the basis
of an Armed Forces of Pathology (AFIP) series. [1] The
prognosis is poor but recent evidence indicates that mod-
ern surgical procedures along with neo adjuvant or adju-
vant chemotherapy have led to an increase in the median
survival. We report a case of a 14 year old Chinese boy
with Undifferentiated Liver Sarcoma.
Case presentation
A 14 year old Chinese boy presented to a district hospital
with a 5 day history of non-specific right hypochondriac
pain. There was no history of jaundice, fever, anorexia or
weight loss. He did not have any other associated symp-
toms. He had no significant past or family history, and no
history of drug intake or allergies. His general physical
examination was unremarkable. Yellowish discoloration
of skin or sclera, spider naevi and palmar erythema all
were absent. Systemic examination revealed massive
hepatomegaly. His blood count and liver function tests
were normal. Alpha fetoprotein was also normal. Ultra-
sonography revealed a large mass in the right lobe of the
liver. He was referred to our hospital for further manage-
ment. Contrast enhanced CT Scan revealed a large,
hypodense mass of 14 × 15 × 15 cm in the right lobe of
the liver. (Figure 1). Exploratory laparotomy was per-
Published: 25 January 2008
Journal of Medical Case Reports 2008, 2:20 doi:10.1186/1752-1947-2-20
Received: 23 December 2006
Accepted: 25 January 2008
This article is available from: http://www.jmedicalcasereports.com/content/2/1/20
© 2008 Iqbal et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Medical Case Reports 2008, 2:20 http://www.jmedicalcasereports.com/content/2/1/20
Page 2 of 3
(page number not for citation purposes)
formed and revealed a large mass in the right lobe of the
liver and part of the left lobe with ruptured capsule and
the ruptured part adhered to pleura. Tumor resection was
performed and about 70% of the total liver was resected.
Pathologic review of the specimen revealed an 1150 gm
right hepatic lobe and part of the left hepatic lobe with a
14 × 15 × 15 cm tumor mass. The histological examina-
tion showed malignant sarcomatous tissue with giant
neoplastic cells and residual hepatocytes suggestive of
Undifferentiated Liver Sarcoma. (Figure 2). Sarcomatous
tissue with severe atypia of the neoplastic cells and focal
presence of giant cells, partially with myoblastic character-
istics, was also present. Immunohistochemical staining
was positive for Phosphoenolpyruvate Carboxy Kinase
(PCK), Vimentin and Alpha 1 Antitrypsin and negative for
Epithelial Membrane Antigen (EMA).
Our patient's postoperative recovery was uneventful. He
was given 6 cycles of adjuvant chemotherapy, AIM Regi-
men (Adriamycin, Ifosfamide and Mesna), which was
well tolerated. A post-chemotherapy CT scan showed no
signs of recurrence and our patient is alive and well 6
months after surgery.
Discussion
Undifferentiated Liver Sarcoma is a rare, highly malignant
neoplasm almost exclusively found in the pediatric popula-
tion although a few cases have been reported in adults.
Undifferentiated Liver Sarcoma was described as a separate
pathological entity by Stocker et al in 1978. [1] Before that
time different nomenclature was used, most commonly
Malignant Mesenchymoma, although Primary Sarcoma of
the Liver, Fibromyxosarcoma and Mesenchymoma were
also used. [2].
Primary hepatic neoplasms are the third most common
solid malignant tumors in children after Wilms Tumour
and Neuroblastoma and they account for about 2% of
total solid pediatric malignancies. Primitive mesenchymal
tumor, although rare, is the fourth most common pediat-
ric malignant hepatic tumor following Hepatoblastoma,
Infantile Haemangioendothelioma and Hepatocellular
Carcinoma. Primitive mesenchymal tumors represent
about 9%-15% of all hepatic tumors in children. Only
about 150 cases have been reported in the literature.
ULS is a malignancy of older children with the majority of
cases diagnosed in children between the ages of 6–10
years. The incidence decreases after 10 years of age. There
is a slight male preponderance in children (1:0.65). [2]
The right lobe of the liver is more commonly involved.
Stocker et al presented a series of 31 cases which showed
ULS as having a poor prognosis with median survival of
less than a year. Recent evidence shows that, with the
advent of modern surgical procedures and the use of pre
and post operative chemotherapy, there has been an
increase in the overall survival rate. A recent review of
published cases revealed a better outlook with 37.5% of
patients alive without disease for an average of 37.5
months.[3] Two further patients were reported alive and
Microphotograph showing malignant sarcomatous tissue with  giant neoplastic cells (H.E Staining × 100) Figure 2
Microphotograph showing malignant sarcomatous tissue with 
giant neoplastic cells (H.E Staining × 100).
Contrast enhanced CT scan showing hepatomegaly and a  large hypodense lesion in the liver Figure 1
Contrast enhanced CT scan showing hepatomegaly and a 
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free of disease more than 5 years after complete surgical
excision of the tumor and chemotherapy.[3]
The clinical features of ULS are often non-specific and
may have varied presentation ranging from sharp abdom-
inal pain, fever, anorexia, diarrhea or a solitary liver cyst.
In our case the only presenting complaint was non-spe-
cific right hypochondriac pain. Fever is usually due to
hemorrhage and necrosis. Rupture into the tumor, perito-
neal cavity or pleura can be present. [4] Jaundice is usually
absent. In contrast with Primary Liver Carcinoma, ULS
has no relationship with hepatitis or cirrhosis. There is
usually no abnormality in liver function and a normal
alpha fetoprotein. Laboratory studies are usually non-spe-
cific. [1,2]
Radiographs of the abdomen are usually normal. The
lesion can be detected by ultrasound, CT and MRI. MRI
localizes the lesion more accurately than the other meth-
ods, with good resectability correlation. It also can detect
vascular invasion, biliary obstruction and hilar adenopa-
thy. [5].
ULS is a neoplasm with a primitive mesenchymal pheno-
type. Tumor size often exceeds 10 cm and they can be as
large as 30 cm. Buetow et al reviewed the pathological and
radiological findings in 28 cases of ULS. [6] Pathologi-
cally, the tumor is usually a large, solitary mass, predomi-
nantly solid, with the rest of it being cystic, filled with
serosanguineous fluid. On ultrasonography, the lesion
appears predominantly solid (iso-hyperechoic when com-
pared to liver parenchyma) with a few cystic areas due to
cystic degeneration or hemorrhage. On CT it appears pre-
dominantly hypodense, foci of hemorrhage appear hyper-
dense and occasionally a fluid-debris level is also noted.
On MRI, the lesion is predominantly of CSF signal inten-
sity with areas of cystic degeneration appearing hypoin-
tense on T1 weighted images and hyperintense on T2
weighted images; there can be hyperintense foci on T1W
images due to hemorrhage. [7] Occasionally, the lesion
can be predominantly cystic on ultrasonography and may
be mistaken for a hydatid cyst. [8]
Although there is no standard treatment mentioned in the
literature for Undifferentiated Liver Sarcoma, surgery with
neo adjuvant or adjuvant chemotherapy [9] remains the
option of choice. Considering the usual large size of the
tumor, neo adjuvant or preoperative chemotherapy seems
to be a logical and reasonable choice which may result in
tumor shrinkage enabling complete resection. Recent
researchers have shown that neo adjuvant or adjuvant
chemotherapy, and/or radiotherapy when necessary, can
remarkably improve a patient's survival. [10] As local
recurrence and distant metastases are common, especially
to peritoneum, pleura and lung, and rarely to the inferior
vena cava, it is worth recommending that adjuvant chem-
otherapy (with Adriamycin, Ifosfamide and Mesna) be
considered in patients presenting with this rare tumor. As
there are no serum markers to evaluate the response or
predict local recurrence, regular abdominal ultrasound or
CT scan should be considered for evaluation and to look
for any possible recurrence.
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